ERBB2 and breast carcinoma: Of the four subtypes, the LA subtype tends to have the best prognosis, fairly high survival, and low recurrent or metastases rates. The TN and HER2 subtypes of breast cancer were associated with a significantly poorer overall survival and prone to earlier recurrence and metastases.